Philip Morris (PM) AI Stock Analysis

Philip Morris

(BMV:PM)

Rating:―N/A

Action:N/A

Date:―

No summary available

Positive Factors

Smoke-free portfolio growth and market sharePMI’s smoke-free portfolio is gaining adoption across IQOS, VEEV, and ZYN, while international share reaches 62%. This supports a durable transition toward recurring consumables revenue, broadens the company’s product base, and creates longer-term growth beyond combustible cigarettes.

Negative Factors

Aggressive leverage and negative equityPersistent negative equity and high debt make PMI’s capital structure structurally aggressive and reduce financial flexibility. Although cash generation is strong, operating cash flow covers only about half to two-thirds of debt in the periods shown, increasing sensitivity to weaker operating conditions.

Philip Morris (PM) vs. SPDR S&P 500 ETF (SPY)

Market Cap: MXN 324.64B
Dividend Yield: 2.89%
Average Volume (3M): 365
Price to Earnings (P/E): 30.4
Beta (1Y): 0.04
Revenue Growth: -3.13%
EPS Growth: 12.37%
Country: Mexico
Employees: 84,900
Sector: Consumer Defensive
Sector Strength: 62
Industry: Tobacco

Philip Morris Business Overview & Revenue Model

Company Description

Philip Morris International Inc. functions as a prominent tobacco enterprise, actively working toward a smoke-free future. The company is strategically diversifying its long-term product range to incorporate items beyond traditional tobacco and nicot...

Philip Morris Earnings Call Summary

Earnings Call Date:Oct 20, 2026(Q3-2026)|% Change Since:2.52%|Next Earnings Date:Feb 10, 2027

Earnings Call SentimentPositive

The call was strongly positive, with record Q3 operating income and EPS, broad-based smoke-free growth, resilient combustibles performance, expanding margins, strong cash generation, and maintained full-year growth guidance. The main challenges were geopolitical and inflationary cost pressures, a substantial temporary investment cycle and profitability decline in U.S. ZYN during Q4, excise-related headwinds in Japan and Poland, and ongoing cigarette volume declines. Overall, the positive operating and financial trends significantly outweighed the explicitly stated challenges.

Positive Updates

Strong Q3 Revenue and Operating Income Growth

Q3 organic net revenue grew +7.1% to $11.4 billion, while adjusted operating income increased +10.5% organically and +9.6% in dollar terms. Gross profit grew organically by more than +8%, supported by strong top-line growth and effective cost management despite accelerated growth investments.

Negative Updates

Geopolitical Cost Pressures Weighed on Earnings

Ongoing conflicts in the Middle East and Ukraine created incremental cost pressures. Management estimates that energy- and input-related inflation will reduce full-year adjusted diluted EPS growth by around half a percentage point, with a similar-sized headwind from disruptions in Ukraine, for a combined impact of approximately one point of growth.

Company Guidance

For 2026, PMI expects growing total shipment volumes, +5% to +7% organic net revenue growth, organic operating income growth of 7%-9%, and currency neutral adjusted diluted EPS growth of 7.5%-9.5%; with a favorable currency impact at prevailing exchange rates of approximately $0.18, adjusted diluted EPS is expected at $8.29-$8.44, representing growth of approximately +10% to +12% in dollar terms, with full-year delivery more likely to be at the midpoint or lower half of both brackets. Smoke-free adjusted IMS volumes and shipments are expected to show high single-digit growth, full-year cigarette volumes to decline by a similar level, full-year pricing to be above 8%, and operating cash flow to reach approximately $13.5 billion. For Q4, PMI expects HTU shipment volumes of 39.5 billion-40.5 billion units, strong international net revenue and OCI performance including a re-acceleration in smoke-free performance, U.S. ZYN shipment volumes broadly in line to modestly above Q3 levels, U.S. adjusted OCI around zero or slightly negative, and an exceptional sequential increase of around 10% in U.S. segment SG&A.

Philip Morris Risk Analysis

Philip Morris disclosed 32 risk factors in its most recent earnings report. Philip Morris reported the most risks in the "Legal & Regulatory" category.

Legal & Regulatory - Litigation, compliance, new legislation, and taxation risks

Latest Risks Added

0 New Risks

Philip Morris Peers Comparison

Overall Rating

UnderperformOutperform

Sector (62)

Financial Indicators

MX:PM against its peers
Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
RLX	69Neutral	$1.97B	13.83	6.20%	6.63%	59.23%	39.66%
BTI	68Neutral	$132.27B	15.66	13.38%	5.37%	4.47%	117.22%
MO	65Neutral	$129.80B	15.94	-279.72%	5.56%	2.41%	-7.63%
TPB	65Neutral	$1.35B	27.93	11.93%	0.47%	20.10%	-3.19%
Sector *	62Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
XXII	40Underperform	$1.34M	0.00	-20.47%	―	-27.44%	99.95%

* Consumer Defensive Sector Average

Performance Comparison

MX:PM and its peers over the selected period
Ticker	Company Name	Price	Change	% Change
MX:PM	Philip Morris International	3790.00	1162.24	44.23%
MO	Altria	77.17	23.49	43.76%
BTI	British American Tobacco	61.91	11.91	23.81%
XXII	22nd Century Group	0.07	-386.93	-99.98%
TPB	Turning Point Brands Inc	66.48	-28.34	-29.89%
RLX	Rlx Technology, Inc.	1.66	-0.61	-26.87%

Glossary

BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Philip Morris AI Stock Analysis